Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- JNJ-101556143Phase 32 trials
Johnson & Johnson (Janssen) · Prostatic Neoplasms
- JNJ-90301900NBTXR3, Functionalized hafnium oxide nanoparticlesPhase 32 trials
Johnson & Johnson (Janssen) · Carcinoma, Squamous Cell, Carcinoma, Non-Small-Cell Lung
- JS105Phase 32 trials
Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors, Breast Cancer
- JYP0322Phase 32 trials
Guangzhou JOYO Pharma Co., Ltd · Non Small Cell Lung Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)
- LAM561Phase 32 trials
Laminar Pharmaceuticals · Primary Glioblastoma, Glioblastoma Multiforme, High-grade Glioma
- LB1410Phase 32 trials
L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer
- LB4330Phase 32 trials
L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer
- NaporafenibLXH254, ERAS-254Phase 32 trials
Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma
- NeladalkibNVL-655Phase 32 trials
Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor
- NP-G2-044PrilukaePhase 32 trials
Novita Pharmaceuticals, Inc. · Platinum-resistant Ovarian Cancer, Advanced or Metastatic Solid Tumor Malignancies
- NuvastaticPhase 32 trials
Natureceuticals Sdn Bhd · Fatigue, Colon Cancer, Breast Neoplasms
- Nuvastatic 300Phase 32 trials
Natureceuticals Sdn Bhd · Fatigue Related to Cancer Treatment, Colon Cancer, Breast Cancer
- OBI-821OBI-833Phase 32 trials
OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer
- OciperlimabBGB-A1217Phase 32 trials
BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies
- of Physician's ChoicePhase 32 trials
BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm
- OSE2101Phase 32 trials
OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma
- PalazestrantOP-1250Phase 32 trials
Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
- PamiparibBGB-290Phase 32 trials
BeOne Medicines (BeiGene) · Ovarian Cancer, Advanced Malignancies
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- PF-08046054SGN-PDL1VPhase 32 trials
Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
- Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials
EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer
- QL0911Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune
- QLS4131Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma
- RC118RC118-ADCPhase 32 trials
RemeGen Co., Ltd. · Advanced Solid Tumor, Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- RezvilutamidePhase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- RP2Phase 32 trials
Replimune, Inc. · Hepatocellular Carcinoma, Biliary Tract Cancer, Metastatic Uveal Melanoma
- RYZ101Phase 32 trials
RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer
- SCTB14Phase 32 trials
Sinocelltech Ltd. · Non-Small Cell Lung Carcinoma (NSCLC), Advanced Malignant Solid Tumours
- SetidegrasibASP3082Phase 32 trials
Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
- SGT-003Phase 32 trials
Solid Biosciences Inc. · Duchenne Muscular Dystrophy, Advanced Solid Tumor
- SHR-2004Phase 32 trials
Beijing Suncadia Pharmaceuticals Co., Ltd · Prevention of Arterial and Venous Thrombosis, Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
- SHR-A1921Phase 32 trials
Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Ovarian Cancer
- SugemalimabPhase 32 trials
Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma
- SV-BR-1-GMthe Bria-IMTPhase 32 trials
BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm
- TGRX-326once a dayPhase 32 trials
Shenzhen TargetRx Co., Ltd. · Non-small Cell Lung Cancer, Non Small Cell Lung Cancer
- tirapazaminePhase 32 trials
Zhejiang Raygene Pharmaceuticals Co., Ltd · HCC, Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic
- TOL2506Phase 32 trials
Tolmar Inc. · Breast Cancer
- TPST-1120Phase 32 trials
Roche (Genentech) · Advanced Liver Cancers, Hepatocellular Carcinoma (HCC)
- TQB2450Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer
- TQB2868Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Pancreatic Neoplasms, Metastatic Pancreatic Ductal Adenocarcinoma
- TQB3454Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Solid Tumors, Biliary Carcinoma
- TR115Phase 32 trials
Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent
- TunlametinibPhase 32 trials
Shanghai Kechow Pharma, Inc. · Colorectal Cancer Metastatic, Melanoma
- TuvonralimabPhase 32 trials
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- UliledlimabPhase 32 trials
TJ Biopharma Co., Ltd. · Non Small Cell Lung Cancer
- US-sourced KeytrudaPhase 32 trials
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer
- VEGF bispecific antibodyPhase 32 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Squamous Non-small-cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer
- VepugratinibLY3866288Phase 32 trials
Eli Lilly · Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3
- VT3989Phase 32 trials
Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult
- XaluritamigAMG 509Phase 32 trials
Amgen · Metastatic Castration-resistant Prostate Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.